BFRG实时信号 | 通过Getagraph.com最大化利润

购买 110476 min ago

@ $4.93

发出时间: 12 Feb 2024 @ 23:12

回报率: -40.97%

上一信号: Feb 9 - 23:26

上一信号: 出售

回报率: 5.12 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	28 428.00
平均成交量	311 158
市值	22.85M
EPS	$0 ( 2024-03-12 )
下一个收益日期	( $0 ) 2024-05-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.27
ATR14	$0.0450 (1.55%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-18	Singh Vininder	Buy	79 000	Stock options (Right to buy)
2024-01-22	Singh Vininder	Sell	25 000	Common Stock
2024-01-18	Saglio Dane R	Buy	34 500	Stock options (Right to buy)
2024-01-16	Singh Vininder	Sell	8 516	Common Stock
2024-01-17	Singh Vininder	Sell	4 848	Common Stock

INSIDER POWER
29.26
Last 22 transactions
Buy: 278 500 \| Sell: 125 000

音量相关性

長: -0.34 (neutral)

短: -0.11 (neutral)

Signal:(52.98) Neutral

Bullfrog AI Holdings, 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Bullfrog AI Holdings, 相关性 - 货币/商品

0.25
( neutral )

0.50
( weak )

0.00
( neutral )

0.24
( neutral )

-0.03
( neutral )

0.25
( neutral )

Bullfrog AI Holdings, 财务报表

Annual	2023
营收:	$65 000.00
毛利润:	$58 075.00 (89.35 %)
EPS:	$-0.890

FY	2023
营收:	$65 000.00
毛利润:	$58 075.00 (89.35 %)
EPS:	$-0.890

FY	2022
营收:	$10 000.00
毛利润:	$9 200.00 (92.00 %)
EPS:	$-0.460

Financial Reports:

No articles found.

Bullfrog AI Holdings,

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.